Eli Lilly’s plant in Cork . US regulator is concerned over experimental lung cancer drug.

Eli Lilly ’s experimental lung cancer drug raised concerns with US regulators that it may increase patients’ risk of suffering potentially deadly blo(...)

Janet Woodcock, FDA director of the agency’s Center for Drug Evaluation and Research: Amarin has taken a pre-emptive First Amendment case, accusing the FDA of restricting its right to free speech

The US Food and Drug Administration seems mildly discomfited. It’s not a state that one usually associates with the most powerful regulator of the pha(...)

Sprout Pharmaceuticals hopes its drug, flibanserin, will mirror the success of Pfizer’s erectile dysfunction drug Viagra. Photographer: JB Reed/Bloomberg News

A US federal advisory panel recommended approval of what would become the first drug to treat a lack of sexual desire in women after an intense lobbyi(...)

MedColl founder Roz Martin, who says the company is supplying approximately 250 pharmacies across Dubai, Abu Dhabi and other cities in the UAE

Irish biotechnology company MedColl has secured a €5 million contract to supply its anti-ageing and skincare supplements into pharmacy chains across t(...)

Foreign pharmaceuticals companies in China have struggled with regulatory problems in recent years, including more stringent approval requirements

US drugmaker Pfizer has halted vaccine sales in China after an import licence for one of its top-selling treatments expired, dealing a blow to the com(...)

Pfizer and Eli Lilly will resume a late-stage study testing their pain drug tanezumab after the US Food and Drug Administration lifted a partial hold (...)

Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sa(...)

Peter Crosby, CEO of  Mainstay Medical: “2014 has been a significant year for Mainstay.”  Photograph:  Nick Bradshaw

Irish medical devices firm Mainstay Medical said 2014 was a significant year for the company, as it completed a stock offering and pushed forward with(...)

An automated machine works on purification of  hepatitis C virus drug. Photographer: David Paul Morris/Bloomberg

Gilead Sciences, whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in US taxes by (...)

Zachary Rubin, medical director of clinical epidemiology speaks at a news conference by UCLA Health System and county officials at the Ronald Reagan UCLA Medical Center in Los Angeles. The large Los Angeles teaching hospital has told scores of patients they were possibly exposed to a drug-resistant bacterial “superbug” during endoscopy procedures that infected seven patients. Photo: Jonathan Alcorn/Reuters

Federal officials warned health care providers Thursday that difficult-to-clean medical scopes inserted down the throat might be infecting patients w(...)